ovarian cancer, tubal cancer, peritoneal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Early ovarian cancer that can be removed without tumor failure (including tubal cancer and borderline malignant ovarian tumors) 2)Advanced stage ovarian cancer (Also includes borderline malignant ovarian tumors, including fallopian tube and peritoneal cancers) treated preoperatively and considered resectable 3)Patients with an ECOG Performance Status of 0 ~ 2 4)Patients with adequate major organ function (laboratory tests should be done within 28 days before surgery) Neutrophil count 1,000/mm3 or greater, platelet count 100,000/mm3 or greater, AST, ALT 100 IU/L or less, serum total bilirubin < 1.5 mg/dl, serum creatinine < 1.5 mg/dl, normal ECG range or no symptoms and no need for treatment (Cases without heart disease or serious arrhythmias) 5)Patients aged 18 years or older at enrollment (upper limit not specified) 6)Patients who provided written consent to participate in the study
Exclusion criteria
Exclusion criteria: 1)Patients who do not meet the inclusion criteria 2)Patients with serious complications Example: Exclude patients with serious cardiac or cerebrovascular disease, difficult-to-control diabetes or hypertension with HbA1c > 8.5%, pulmonary fibrosis, interstitial pneumonia, bleeding, active peptic ulcer disease, or serious neurological disease. 3)Patients who are expected to have difficulty completing or following up with the study or who are deemed unsuitable by their physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of intestinal obstruction within 30 days of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative complications (other than bowel obstruction) within 30 days of surgery, recurrence-free survival, and overall survival | — |
Countries
Japan
Contacts
Oita University Obstetrics and Gynecology